Back to search
FDAFDA · Food and drugs·Recall number D-0439-2017

Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories Inc., Corona, CA 92880 USA, Mfd. by Cipla Ltd. Verna, Goa India, NDC 0591-3467-53

Published February 1, 2017 · Recall initiated: January 12, 2017

Summary

FDA records drug Class III recall D-0439-2017, published February 1, 2017 and initiated January 12, 2017. Recalling firm: Actavis Inc; Status: Terminated; Reported quantity: 164,844 units; Lot: Lot #: GA51265, Ex[p. Jan-2017, GA51454, GA51553, GA51583, Exp. Feb-2017, GA51598, GA51724, GA51725, GA51749, Exp. Mar-2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis Inc
Distributor
Nationwide in the US
Lot
Lot #: GA51265, Ex[p. Jan-2017, GA51454, GA51553, GA51583, Exp. Feb-2017, GA51598, GA51724, GA51725, GA51749, Exp. Mar-2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories Inc., Corona, CA 92880 USA, Mfd. by Cipla Ltd. Verna, Goa India, NDC 0591-3467-53 recalled?

Yes. FDA published recall D-0439-2017 on February 1, 2017. Reported hazard: Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.

What should I do if I have this product?

Voluntary: Firm initiated · Letter